NEXT PET-MRI: cutting-edge brain imaging
Providing researchers with an increasingly accurate view of the brain
One step closer to excellence in medical imaging
Brain imaging provides a unique window into how the human brain functions. Thanks to the PET-MRI scanner acquired in 2015, researchers and clinicians at Paris Brain Institute now have a cutting-edge tool for observing brain structures and monitoring the progression of neurological diseases. This equipment combines the metabolic precision of PET with the anatomical detail of MRI, providing a better understanding of complex pathologies such as head trauma, neurodegenerative diseases, and psychiatric disorders.
However, since its introduction 10 years ago, the technology has evolved rapidly. New, faster, and more accurate MRI sequences are now available, as are advanced artificial intelligence algorithms capable of extracting an unprecedented amount of biomedical information. Updating our technological equipment means providing researchers and doctors with the most effective tools to continue advancing science and improving patient care.
OUR CHALLENGE
Providing head trauma patients with increasingly effective diagnostic and monitoring tools.
A state-of-the-art imaging tool is not just a machine: it is a catalyst for discovery. Each technological improvement paves the way for major advances, enabling better diagnosis, understanding, and treatment of brain disorders.
Maintaining cutting-edge research
In a competitive scientific environment, staying at the forefront of innovation is crucial. A technological lag could jeopardize international collaborations and limit access to large-scale research funding. With this equipment update, Paris Brain Institute will not only be able to continue its multicenter studies with the world’s leading centers, but also to attract the most ambitious projects.
Ensuring better detection and monitoring of brain injuries
Brain disorders develop slowly, often in ways that are invisible to conventional tools. With this new equipment, researchers will be able to detect early markers of neurodegenerative diseases, analyze head injuries in greater detail, and develop new therapeutic strategies. This will directly benefit patients by enabling earlier diagnosis and more accurate monitoring.
“This state-of-the-art system means we will be able to offer researchers and clinicians an imaging tool that is increasingly accurate and tailored to the needs of patients and future research projects.”
Eric Bardinet
Operations Manager of the CENIR imaging platform at Paris Brain Institute
TARGET AMOUNT
€600,000 – €700,000
TO FUND
- Improved resolution and signal quality
- New MRI sequences for improved analysis of brain microstructure
- The development of algorithms to correct patient movements
- The integration of advances in artificial intelligence to refine biomarker analysis